Cargando…
No Differences in Levels of Circulating Progenitor Endothelial Cells or Circulating Endothelial Cells Among Patients Treated With Ticagrelor Compared With Clopidogrel During Non–ST‐Segment–Elevation Myocardial Infarction
BACKGROUND: Ticagrelor use during acute coronary syndromes demonstrated a decrease in all‐cause mortality in the PLATO (Platelet Inhibition and Patient Outcomes) trial. This effect has been attributed to a non–platelet‐derived improvement in endothelial function. The aim of this study was to determi...
Autores principales: | Diego‐Nieto, Alejandro, Vidriales, Maria B., Alonso‐Orcajo, Norberto, Moreno‐Samos, Jose C., Martin‐Herrero, Francisco, Carbonell, Raul, Cid, Belen, Cruz‐Gonzalez, Ignacio, Martin‐Moreiras, Javier C., Cuellas, Carlos, Pascual, Cristina, Lopez‐Benito, Maria, Sanchez, Pedro L., Fernandez‐Vazquez, Felipe, de Prado, Armando Perez |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6404906/ https://www.ncbi.nlm.nih.gov/pubmed/30371302 http://dx.doi.org/10.1161/JAHA.118.009444 |
Ejemplares similares
-
Modulation of Circulating MicroRNAs Levels during the Switch from Clopidogrel to Ticagrelor
por: Carino, Annarita, et al.
Publicado: (2016) -
The effect of antiplatelet drug on coronary endothelial and microvascular function: comparison with ticagrelor and clopidogrel
por: Choi, Woong Gil, et al.
Publicado: (2021) -
Ticagrelor Improves Endothelial Function by Decreasing Circulating Epidermal Growth Factor (EGF)
por: Vieceli Dalla Sega, Francesco, et al.
Publicado: (2018) -
The Effect of Ticagrelor on Endothelial Function Compared to Prasugrel, Clopidogrel, and Placebo: A Systematic Review and Meta-Analysis
por: Guan, Baoyi, et al.
Publicado: (2022) -
Circulating Endothelial Cells, Circulating Endothelial Progenitor Cells, and
Circulating Microparticles in Type 1 Diabetes Mellitus
por: Zahran, Asmaa M., et al.
Publicado: (2019)